ReviewCancers2022

Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma.

Landon L Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.